PocDoc, a Cambridge, UK-based health-tech startup, raised £5M in Pre-A funding.
Backers included MMC Ventures, Molten VC and Simplyhealth Ventures, and KHP Ventures.
The corporate intends to make use of the funds to assist its continued fast development, accelerated by its listing of pharmacy, retail, and company partnerships, in addition to its relationships with the NHS throughout the UK.
Based by Steve Roest, Dr Vladimir Gubala and Dr Kiran Roest, PocDoc goals to make diagnostic testing for cardio, metabolic and renal illness as accessible as doable, to stop these ailments from crippling well being programs all around the world. It gives an app-based know-how platform that mixes proprietary, patented Microfluidic Assay (MFA) know-how and cloud-based AI diagnostics to ship end-to-end digital pathways for the evaluation, analysis and remedy of main ailments.
Its patented MFA (microfluidic Assay) platform is a digital diagnostic check platform that may carry out complicated multi-marker interactions to a clinically legitimate normal.
The PocDocOS® platform gives the digital infrastructure for the way forward for level of care testing. Utilizing machine studying, knowledge and course of integration, dynamic workflows, medical groups and real-time alerting, it allows anybody with a smartphone or pill to obtain a full well being evaluation and demanding observe on providers, together with chatting with a clinician, notifying GP, sending outcomes to affected person report and offering real-time remedy choices.
PocDoc’s exams can be found at no cost in areas the place the corporate is already working with the NHS, in neighborhood pharmacies throughout the UK, by way of on-line retailers resembling Pharmacy2U, and on PocDoc’s web site.
FinSMEs
28/11/2024
